Compare Neurocrine Biosciences Inc (NBIX) vs VICI Properties Inc (VICI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Neurocrine Biosciences Inc vs VICI Properties Inc — how do they compare? Neurocrine Biosciences Inc trades at $179.88 (market cap $17.40B), while VICI Properties Inc trades at $26.59 (market cap $29.55B). The key difference: VICI Properties Inc is the larger of the two by market cap, and VICI Properties Inc pays a 6.71% dividend while Neurocrine Biosciences Inc pays none. Which is the better fit depends on your goals.
| NBIX | VICI | |
|---|---|---|
Market Cap | $17.40B | $29.55B |
Sector | Health | Real Estate |
52-Week High | $180.55 | $33.93 |
52-Week Low | $123.10 | $25.94 |
Enterprise Value | $16.49B | $46.77B |
Dividend Yield | — | 6.71% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →About VICI Properties Inc
VICI Properties is an S&P 500 experiential real estate investment trust (REIT) that owns one of the largest portfolios of market-leading gaming, hospitality, and entertainment destinations, including Caesars Palace and MGM Grand. It utilizes a long-term, triple-net lease model to provide stable, inflation-protected income, serving as the primary landlord for the 'experience economy' while diversifying into non-gaming sectors like wellness, youth sports, and luxury resorts.
Read more on VICI →
